Endogenous estrogen levels, bone mineral density and estrogen receptor status in breast cancer.
Altundag
Kadri
K
Altundag
Ozden
O
Gunduz
Mehmet
M
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004967:Estrogens / Q000097:blood* / Q000494:pharmacology*; D005260:Female; D006801:Humans; D017698:Postmenopause; D017697:Premenopause; D011960:Receptors, Estrogen; D015203:Reproducibility of Results; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D004967:Estrogens; D011960:Receptors, Estrogen; D013629:Tamoxifen